Nuwellis (NUWE) Gross Margin Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -67.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -54.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -265.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 62.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -65.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 610.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -359.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 58.00 |
| 10 | Nuwellis | 1.45 Mn | -630,292.49 | 1.68 Mn | 1,404.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,404.00 |
| Dec 31, 2025 | 988.00 |
| Sep 30, 2025 | -478.00 |
| Jun 30, 2025 | -1,165.00 |
| Mar 31, 2025 | -810.00 |
| Dec 31, 2024 | 394.00 |
| Sep 30, 2024 | 1,271.00 |
| Jun 30, 2024 | 1,191.00 |
| Mar 31, 2024 | 570.00 |
| Dec 31, 2023 | -249.00 |
| Sep 30, 2023 | -371.00 |
| Jun 30, 2023 | 724.00 |
| Mar 31, 2023 | 122.00 |
| Dec 31, 2022 | 246.00 |
| Sep 30, 2022 | 53.00 |
| Jun 30, 2022 | -1,221.00 |
| Mar 31, 2022 | 685.00 |
| Dec 31, 2021 | -162.00 |
| Sep 30, 2021 | 1,433.00 |
| Jun 30, 2021 | -411.00 |
| Mar 31, 2021 | -80.00 |
| Dec 31, 2020 | 530.00 |
| Sep 30, 2020 | -1,076.00 |
| Jun 30, 2020 | 1,415.00 |
| Mar 31, 2020 | 154.00 |
| Dec 31, 2019 | 1,641.00 |
| Sep 30, 2019 | 2,400.00 |
| Jun 30, 2019 | 2,937.00 |
| Mar 31, 2019 | 3,651.00 |
| Dec 31, 2018 | 3,676.00 |
| Sep 30, 2018 | 1,458.00 |
| Jun 30, 2018 | -787.00 |
| Mar 31, 2018 | -2,984.00 |
| Dec 31, 2017 | -3,190.00 |
| Sep 30, 2017 | -4,728.00 |